The company said worldwide sales for Q2 2026 totaled approximately $2.96 billion, increasing 5% on both a reported and organic basis, with growth in all segments and divisions.

1. 01

   The company said worldwide sales for Q2 2026 totaled approximately $2.96 billion, increasing 5% on both a reported and organic basis, with growth in all segments and divisions.

2. 02

   Baxter said its U.S. GAAP net income for Q2 was $135 million ($0.26 per diluted share), and adjusted diluted EPS was $0.56, down 5% from the prior year. The company cited the IEEPA tariff refund as a benefit of $0.11 per diluted share.

3. 03

   The company said free cash flow was $181 million in Q2 and $257 million in the first half of 2026.

4. 04

   Baxter said it raised its full-year adjusted earnings from continuing operations per diluted share outlook to $1.95 to $2.15, from the previous outlook of $1.85 to $2.05. It also said it declared a quarterly cash dividend of $0.01 per share on July 29, 2026.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the opening part of the filing body and confirmed exhibits, within a length limit. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.